Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Anderson

Showing results (361-370 of 400) with videos related to

Pageof 40
Sort By:
Pharmaceutics|September 23, 2022
Modeling the Probability of HIV Infection over Time in High-Risk Seronegative Participants Receiving Placebo in Five Randomized Double-Blind Placebo-Controlled HIV Pre-Exposure Prophylaxis Trials: A Patient-Level Pooled AnalysisMaria Garcia-Cremades, Craig W Hendrix, Priya Jayachandran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2022
Characterizing HIV-Preventive, Plasma Tenofovir Concentrations-A Pooled Participant-level Data Analysis From Human Immunodeficiency Virus Preexposure Prophylaxis Clinical TrialsMaria Garcia-Cremades, Katarina Vučićević, Craig W Hendrix, et al.
European Addiction Research|October 25, 2014
Prevalence of and potential influencing factors for alcohol dependence in EuropeJürgen Rehm, Peter Anderson, Joe Barry, et al.
International Journal of Environmental Research and Public Health|January 21, 2022
Costs of an Alcohol Measurement Intervention in Three Latin American CountriesAdriana Solovei, Jakob Manthey, Peter Anderson, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|November 1, 2021
School Readiness in Children Born <30 Weeks' Gestation at Risk for Developmental Coordination Disorder: A Prospective Cohort StudyAlicia J Spittle, Joy E Olsen, Tara L FitzGerald, et al.
The European Journal of General Practice|October 13, 2017
Impact of practice, provider and patient characteristics on delivering screening and brief advice for heavy drinking in primary healthcare: Secondary analyses of data from the ODHIN five-country cluster randomized factorial trialPeter Anderson, Karolina Kłoda, Eileen Kaner, et al.
Implementation Science : IS|January 26, 2013
Implementing training and support, financial reimbursement, and referral to an internet-based brief advice program to improve the early identification of hazardous and harmful alcohol consumption in primary care (ODHIN): study protocol for a cluster randomized factorial trialMyrna N Keurhorst, Peter Anderson, Fredrik Spak, et al.
Journal of Global Health|March 31, 2022
Reduced alcohol consumption during the COVID-19 pandemic: Analyses of 17 000 patients seeking primary health care in Colombia and MexicoJakob Manthey, Sinclair Carr, Peter Anderson, et al.
Frontiers in Research Metrics and Analytics|July 25, 2025
Indigenous rights-based approaches to decolonising research methodologies in settler colonial contextsPeter Anderson, Zane M Diamond, Thu Pham, et al.
Clinical Pharmacokinetics|November 12, 2025
Development of a Semi-Mechanistic Population Pharmacokinetic Model for Predicting Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Exposure in Plasma and Cellular Matrices During Pregnancy and PostpartumYifan Yu, Kristina M Brooks, Gustavo F Doncel, et al.
Pageof 40

Showing results (361-370 of 400) with videos related to

Sort By:
Pageof 40
Pharmaceutics|September 23, 2022
Modeling the Probability of HIV Infection over Time in High-Risk Seronegative Participants Receiving Placebo in Five Randomized Double-Blind Placebo-Controlled HIV Pre-Exposure Prophylaxis Trials: A Patient-Level Pooled AnalysisMaria Garcia-Cremades, Craig W Hendrix, Priya Jayachandran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2022
Characterizing HIV-Preventive, Plasma Tenofovir Concentrations-A Pooled Participant-level Data Analysis From Human Immunodeficiency Virus Preexposure Prophylaxis Clinical TrialsMaria Garcia-Cremades, Katarina Vučićević, Craig W Hendrix, et al.
European Addiction Research|October 25, 2014
Prevalence of and potential influencing factors for alcohol dependence in EuropeJürgen Rehm, Peter Anderson, Joe Barry, et al.
International Journal of Environmental Research and Public Health|January 21, 2022
Costs of an Alcohol Measurement Intervention in Three Latin American CountriesAdriana Solovei, Jakob Manthey, Peter Anderson, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|November 1, 2021
School Readiness in Children Born <30 Weeks' Gestation at Risk for Developmental Coordination Disorder: A Prospective Cohort StudyAlicia J Spittle, Joy E Olsen, Tara L FitzGerald, et al.
The European Journal of General Practice|October 13, 2017
Impact of practice, provider and patient characteristics on delivering screening and brief advice for heavy drinking in primary healthcare: Secondary analyses of data from the ODHIN five-country cluster randomized factorial trialPeter Anderson, Karolina Kłoda, Eileen Kaner, et al.
Implementation Science : IS|January 26, 2013
Implementing training and support, financial reimbursement, and referral to an internet-based brief advice program to improve the early identification of hazardous and harmful alcohol consumption in primary care (ODHIN): study protocol for a cluster randomized factorial trialMyrna N Keurhorst, Peter Anderson, Fredrik Spak, et al.
Journal of Global Health|March 31, 2022
Reduced alcohol consumption during the COVID-19 pandemic: Analyses of 17 000 patients seeking primary health care in Colombia and MexicoJakob Manthey, Sinclair Carr, Peter Anderson, et al.
Frontiers in Research Metrics and Analytics|July 25, 2025
Indigenous rights-based approaches to decolonising research methodologies in settler colonial contextsPeter Anderson, Zane M Diamond, Thu Pham, et al.
Clinical Pharmacokinetics|November 12, 2025
Development of a Semi-Mechanistic Population Pharmacokinetic Model for Predicting Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Exposure in Plasma and Cellular Matrices During Pregnancy and PostpartumYifan Yu, Kristina M Brooks, Gustavo F Doncel, et al.
Pageof 40